Cargando…

Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy

Myocardial hypertrophy is a pathological feature of many heart diseases. This is a complex process involving all types of cells in the heart and interactions with circulating cells. This study is aimed at identifying the differentially expressed proteins (DEPs) in myocardial hypertrophy rats induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xi, Su, Fuxiang, Kang, Ze, Li, Jingyuan, Zhang, Chenyang, Zhang, Yujia, Hao, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085328/ https://www.ncbi.nlm.nih.gov/pubmed/35599721 http://dx.doi.org/10.1155/2022/2715084

Ejemplares similares

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

The CaMKII phosphorylation site Thr1604 in the Ca(V)1.2 channel is involved in pathological myocardial hypertrophy in rats
por: Li, Jingyuan, et al.
Publicado: (2020)

Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats
por: Yuan, Yonggang, et al.
Publicado: (2017)

Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner
por: Zhang, Jingyao, et al.
Publicado: (2018)

Puerarin attenuates isoproterenol-induced myocardial hypertrophy via inhibition of the Wnt/β-catenin signaling pathway
por: Wang, Xiaoying, et al.
Publicado: (2022)

The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
por: Gan, Mailin, et al.
Publicado: (2020)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022)

Isoproterenol pre-treatment improve the therapeutic efficacy of cardiosphere-derived cells transplantation for myocardial infarction
por: Duan, Xiaoying, et al.
Publicado: (2023)

Rapamycin Attenuated Cardiac Hypertrophy Induced by Isoproterenol and Maintained Energy Homeostasis via Inhibiting NF-κB Activation
por: Chen, Xi, et al.
Publicado: (2014)

Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart
por: Sun, Junhui, et al.
Publicado: (2019)

Xin-Ji-Er-Kang Alleviates Isoproterenol-Induced Myocardial Hypertrophy in Mice through the Nrf2/HO-1 Signaling Pathway
por: Yu, Ting-Ting, et al.
Publicado: (2022)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
por: Al-rasheed, Nouf M, et al.
Publicado: (2015)

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun
por: Ming, Su, et al.
Publicado: (2018)

Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction
por: Boarescu, Paul-Mihai, et al.
Publicado: (2019)

Sulforaphane Attenuates Isoproterenol-Induced Myocardial Injury in Mice
por: Song, Lijuan, et al.
Publicado: (2020)

STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways
por: Liu, Fei, et al.
Publicado: (2020)

Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ
por: Li, Hongming, et al.
Publicado: (2023)

MBNL1 regulates isoproterenol‐induced myocardial remodelling in vitro and in vivo
por: Xu, Yao, et al.
Publicado: (2020)

Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis
por: Althurwi, Hassan N., et al.
Publicado: (2020)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy
por: KUBERAPANDIAN, Dharaniyambigai, et al.
Publicado: (2021)

Cardioprotective effect of fenugreek on isoproterenol-induced myocardial infarction in rats
por: Murugesan, Madhesh, et al.
Publicado: (2011)

Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats
por: Goyal, Sameer N., et al.
Publicado: (2015)

Ginsenoside Re Attenuates Isoproterenol-Induced Myocardial Injury in Rats
por: Wang, Quan-wei, et al.
Publicado: (2018)

Cardioprotection of cortistatin against isoproterenol-induced myocardial injury in rats
por: Chen, Wenjia, et al.
Publicado: (2020)

Cardioprotective Effect of Linalool against Isoproterenol-Induced Myocardial Infarction
por: Mohamed, Maged E., et al.
Publicado: (2021)

Cardioprotective Effects of Aconite in Isoproterenol-Induced Myocardial Infarction in Rats
por: Xing, Ziwei, et al.
Publicado: (2022)

Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication
por: Gupta, Prachi, et al.
Publicado: (2013)

Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy
por: Aluja, David, et al.
Publicado: (2022)

Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
por: Galindo, Cristi L, et al.
Publicado: (2009)

A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats
por: Chowdhury, Debabrata, et al.
Publicado: (2013)

Allylmethylsulfide, a Sulfur Compound Derived from Garlic, Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Mohammed, Soheb Anwar, et al.
Publicado: (2020)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Effectual Endeavors of Silk Protein Sericin against Isoproterenol Induced Cardiac Toxicity and Hypertrophy in Wistar Rats
por: Ahsan, Farogh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_264ftcm8l8rbn78f5pr0jnfmbc